F O R I M M E D I A T E R E L E A S E
Attention: Health, Lifestyle, Science, and Business Assignment Editors:
Your pet has a new best friend
The revolutionary joint supplement Sasha's Blend receives the stamp of scientific approval. Major insurance companies will now reimburse Sasha's Blend.
MARCH 2008
(Toronto, ON) – Interpath Pty Ltd., is pleased to announce its peer reviewed published findings from the University of Gueplh in the highly rated scientific journal - Molecular Nutrition Food Research, 2007, 51, 1020 -1030.
The findings represent empirical and scientific proof that its Sasha's Blend product increases joint mobility in pets and helps prevent cartilage breakdown. The findings were the result of studies that strenuously met pharmaceutical requirements.
As a direct result of its conclusions major pet insurance companies had indicated they will reimburse patients claims for its purchase of Sasha's Blend from veterinary clinics. Sasha's Blend is a unique formulation, an Australian success story and one of the fastest-growing neutraceutical alternatives to conventional anti-inflammatories (arthritis drugs) in Canada. Satisfied veterinarians, and their patients in Canada have backed Sasha's Blend since 2002. It has been dubbed by some as the “holy grail” in the search for a natural treatment for arthritis and related joint conditions.
About Sasha's Blend™
Sasha's Blend is Interpath's flagship product. It is a carefully-developed whole food additive harvested from the sea, a concentrated powdered mix of abalone, marine cartilage, and New Zealand Green Lipped Mussel. It has been manufactured in a way to maintain maximum integrity of the actives, and naturally provide many of the nutrients required to help keep joints healthy. These ingredients have been carefully blended to produce a high-quality, highly effective anti-inflammatory, which is designed not only to reduce pain and inflammation, but also to protect cartilage from breakdown associated with arthritis and other inflammatory cartilage conditions.
In addition to the companion animal market segment, Interpath also has a separate human health division. JointXL is for individuals who are interested in slowing or breaking the degenerative cycle of arthritis, reducing pain and inflammation, and protecting the cartilage from breakdown. Health Canada has approved applications for an NPH # (Natural Health Products Number) and JointXL is now available in health food stores.
About Interpath Pty Ltd.
Interpath Pty Ltd. is an industry leader specializing in the scientific research and development for the treatment of tissue and cellular inflammation. The company is globally positioned as the forerunner in the revolution of non-pharmaceutical treatment of arthritis and prevention of joint disease in humans and animals. Interpath Pty Ltd. was established with a view to developing global markets for health-based products. For product information visit www.sashasblend.com - www.jointxl.com.
Interpath Pty Ltd. is a multi-national company headquartered in Ballarat Australia, with offices in the Canada, U.S., The Netherlands, and South Africa, and distributors in Ireland, New Zealand, China, Singapore, Japan, Hong Kong and Portugal. It also has contracted research facilities in Australia, Canada and New Zealand. For more information visit Interpath's website at www.interpath.net.au
To read the abstract please click here
